Intravenous proton pump inhibitors for gastric anti-secretory treatment when oral therapies are unsuitable

Published on 01 Apr 2020
Last Updated on 01 Apr 2020

Guidance Recommendations

The Ministry of Health’s Drug Advisory Committee has recommended:

• Omeprazole 40 mg injection; and

• Pantoprazole 40 mg injection

in line with their registered indications in Singapore for gastric anti-secretory treatment when oral therapies are unsuitable.

Subsidy status

Omeprazole 40 mg injection and pantoprazole 40 mg injection are recommended for inclusion on the MOH Standard Drug List (SDL) for the abovementioned indication.

SDL subsidy does not apply to esomeprazole 40 mg injection.

IV PPIs for gastric anti-secretory treatment (1 Apr 2020) [PDF, 41 KB]

IV PPIs for gastric anti-secretory treatment PES (1 Apr 2020) [PDF, 30 KB]